(CELG:Consolidated Issue Listed on NASDAQ Global Select )
Thomas O. Daniel M.D.
President of Research & Early Development and Executive Vice President, Celgene Corporation
|Age||Total Calculated Compensation||This person is connected to 28 board members in 2 different organizations across 6 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Thomas O. Daniel, M.D., has been the President of Research & Early development of Celgene Corporation since December 2006 and also serves as its Executive Vice President since February 15, 2012. Dr. Daniel has more than two decades of medical and pharmaceutical research experience and served as the Chief Scientific Officer at Ambrx Inc. since September 2003. He served as the Vice President of Research at Amgen Inc., where he served as Research Site Head of Amgen ...
86 Morris AvenuePhone: 908-673-9000
Summit, New Jersey 07901
Board Members Memberships*
University of Texas Southwestern Medical Center - Dallas
|Giovanni Caforio M.D.||Chief Executive Officer and Director|
Bristol-Myers Squibb Company
|George A. Scangos Ph.D.||Chief Executive Officer and Director|
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|J. Michael Pearson||Chairman and Chief Executive Officer|
Valeant Pharmaceuticals International, Inc.
|$1.9M||Compensation as of Fiscal Year 2014.|